David J. Horin
2017 - Array BioPharma
In 2017, David J. Horin earned a total compensation of $83K as Interim Chief Financial Officer at Array BioPharma, a 59% decrease compared to previous year.
Compensation breakdown
Other | $82,950 |
---|---|
Total | $82,950 |
Horin received $83K in other compensation, accounting for 100% of the total pay in 2017.
Rankings
In 2017, David J. Horin's compensation ranked 14,474th out of 14,666 executives tracked by ExecPay. In other words, Horin earned more than 1.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 14,474 out of 14,666 | 1st |
Division Manufacturing | 5,696 out of 5,772 | 1st |
Major group Chemicals And Allied Products | 2,049 out of 2,075 | 1st |
Industry group Drugs | 1,705 out of 1,731 | 2nd |
Industry Pharmaceutical Preparations | 1,314 out of 1,333 | 1st |
Source: SEC filing on September 13, 2017.
Horin's colleagues
We found five more compensation records of executives who worked with David J. Horin at Array BioPharma in 2017.